摘要
Glioma remains the most frequent malignancy of the central nervous system. Recently, necroptosis has been identified as a cell death process that mediates the proliferation and development of tumor cells. LncRNAs play a key role in the diagnosis and treatment of various diseases. However, the impact that necrosis-related lncRNAs (NRLs) have on glioma remains unclear. In our studies, we selected 9 NRLs to construct a prognostic model. Meanwhile, we assessed the survival curves of these 9 NRLs. Our findings found ADGRA1-AS1 and WAC-AS1 were protective lncRNAs, while MIR210HG, LINC01503, CRNDE, HOXC-AS1, ZIM2-AS1, MIR22HG and PLBD1-AS1 were risk lncRNAs. Specifically, 12 immune cells, 25 immune-correlated pathways, and TME score were differentially expressed in the both risk groups. Additionally, the study predicted and validated the necroptosisrelated lncRNA CRNDE/miR-23b-3p/IDH1 axis. CRNDE was strongly expressed in glioma specimens and several cell lines. Inhibiting CRNDE resulted in a substantial reduction in the proliferation and migration of U-118MG and U251 cells. Furthermore, the study predicted that CRNDE may exhibit oncogenic features by adsorbing miR-23b3p and positively regulating IDH1 expression. Overall, the study constructed a prognostic model in glioma, and predicted a lncRNA CRNDE/miR-23b-3p/IDH1 axis, which could potentially be useful for gene therapy of glioma.
学科与关键词
- Comprehensive analysis: Necroptosis-related lncRNAs can effectively predict the prognosis of glioma patientsChen, Desheng; Dou, Chao; Liu, Haiyu; Xu, Binshun; Hu, Bowen; Kuang, Liangwen; Yao, Jiawei; Zhao, Yan; Yu, Shan; Li, Yang; Wang, Fuqing*; Guo, Mian*Frontiers in Oncology, 2022, 12: 929233.被引 4
- A necroptosis-related lncRNA signature was identified to predict the prognosis and immune microenvironment of IDH-wild-type GBMSong, Chong; Zhu, Liwen; Gu, Junwei; Wang, Tong; Shi, Linyong; Li, Chiyang; Chen, Lei; Xie, Sidi*; Lu, Yuntao*Frontiers in Oncology, 2022, 12: 1024208.被引 2
- A novel model based on necroptosis-related genes for predicting immune status and prognosis in gliomaYuan, Ying-Shi; Jin, Xin; Chen, Lu; Liao, Jia-Min; Zhang, Yang; Yu, Ke-Wei; Li, Wei-Kang; Cao, Shun-Wang; Huang, Xian-Zhang*; Kang, Chun-Min*Frontiers in Immunology, 2022, 13: 1027794.被引 2
